Multi-Objective Optimization of Population-Level Dosing Regimens

BACKGROUND AND OBJECTIVE: Drug treatment optimization involves multiple competing objectives, including efficacy, toxicity, resistance, and cost. It is further complicated by interindividual variability that can make standardized regimens suboptimal for individual patients. We developed a population pharmacokinetics- pharmacodynamics (PKPD)-based framework to optimize dosing regimen at the population-level while accounting for interindividual variability, covariate distributions, and clinical expert input. METHODS: The framework optimizes treatment design parameters, including dose and dosing frequency, to maximize population attainment of treatment objectives. Individual attainment of these objectives is estimated using a population PKPD model and quantified into a penalty metric to enable multi-objective dose regimen optimization. Clinical expert input is incorporated through two approaches: 1) multi-criteria decision analysis (MCDA)-based objective weight assignment and 2) gate optimization, an approach to search for a treatment design for which target attainment is equal to or greater than a reference treatment across all objectives. RESULTS: The framework was evaluated in case studies to highlight how this approach can support complex treatment design, incorporate clinical expert input, and integrate covariate information. Grid search evaluation confirmed that the framework identifies solutions close to the expected location of the global optimum. CONCLUSION: The presented framework is adaptable to diverse patient and disease contexts and supports population-level, model-informed dosing optimization.

Authors

Institutions

Publication Details

Journal
Clinical Pharmacokinetics
Published
2026-11-12
DOI
https://doi.org/10.1007/s40262-026-01714-5
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multi-Objective Optimization of Population-Level Dosing Regimens

Sebastian Tommi Tandar, Tingjie Guo, J. G. Coen van Hasselt, Rob Christiaan van Wijk et al.
Clinical Pharmacokinetics
Pharmaceutical studies and practices
article

Multi-Objective Optimization of Population-Level Dosing Regimens

Sebastian Tommi Tandar, Tingjie Guo, J. G. Coen van Hasselt, Rob Christiaan van Wijk, Linda B. S. Aulin, Massinissa Beldjenna, Kieran Nicholl-Morris
article en

Abstract

BACKGROUND AND OBJECTIVE: Drug treatment optimization involves multiple competing objectives, including efficacy, toxicity, resistance, and cost. It is further complicated by interindividual variability that can make standardized regimens suboptimal for individual patients. We developed a population pharmacokinetics- pharmacodynamics (PKPD)-based framework to optimize dosing regimen at the population-level while accounting for interindividual variability, covariate distributions, and clinical expert input. METHODS: The framework optimizes treatment design parameters, including dose and dosing frequency, to maximize population attainment of treatment objectives. Individual attainment of these objectives is estimated using a population PKPD model and quantified into a penalty metric to enable multi-objective dose regimen optimization. Clinical expert input is incorporated through two approaches: 1) multi-criteria decision analysis (MCDA)-based objective weight assignment and 2) gate optimization, an approach to search for a treatment design for which target attainment is equal to or greater than a reference treatment across all objectives. RESULTS: The framework was evaluated in case studies to highlight how this approach can support complex treatment design, incorporate clinical expert input, and integrate covariate information. Grid search evaluation confirmed that the framework identifies solutions close to the expected location of the global optimum. CONCLUSION: The presented framework is adaptable to diverse patient and disease contexts and supports population-level, model-informed dosing optimization.

Clinical Pharmacokinetics
Leiden University (NL)
Longfonds, Lung Foundation Netherlands
Good health and well-being
Pharmaceutical studies and practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon